000			03135nam a22003735i 4500
001			84996
003			ES-MaUEC
005			20230207040450.0
007			cr nn 008mamaa
008			160513s2016 gw | s |||| 0|eng d
020			_a9783319240978
040			_aES-MaUEC
050		4	_aRE48 _b2016 EB
082	0	4	_a617.7
245	1	0	_aAnti-Angiogenic Therapy in Ophthalmology _cedited by Andreas Stahl
264		1	_aCham _bSpringer International Publishing _c2016
300			_a1 recurso en línea (X, 193 páginas) _b26 ilustraciones, 23 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	0		_aEssentials in Ophthalmology _x1612-3212
505	0		_aRetinal Vascular Development -- Retinopathy of Prematurity -- Anti-Vascular Endothelial Growth Factor (VEGF) Treatment in Neovascular Age-Related Macular Degeneration: Outcomes and Outcome Predictors -- AREDS Supplementation and the Progression Towards Neovascular Exudative AMD -- VEGF-Inhibition in Macular Telangiectasia Type 2 -- Diabetic Retinopathy -- Retinal Vein Occlusion -- Pharmacokinetics of Intravitreally Applied VEGF Inhibitors -- Neovascular Glaucoma -- Corneal Neovascular Diseases -- Anti-Angiogenic Gene Therapy - Basic Science and Challenges for Translation into the Clinic.
520			_aThis book provides a concise overview over the pathology of retinal angiogenic diseases and explains why anti-angiogenic therapy is effective in so many patients. The reader is guided through the various clinical indications for anti-angiogenic therapy and made aware of its merits as well as current challenges and limitations. It is explained how, since its introduction for the treatment of exudative age-related macular degeneration in 2006, anti-angiogenic therapy has revolutionized the way in which we treat a range of ocular diseases. All of the authors are established experts in their respective fields who share their extensive knowledge and clinical experience with the reader. This book is both a valuable introduction to anti-angiogenic therapy in ophthalmology and a day-to-day companion for all ophthalmologists seeing patients with some of the most prevalent retinal diseases.
650		7	_aOjos _xEnfermedades _2embne _9168866
700	1		_aStahl, Andreas. _eeditor literario _997634 _0Local _0http://id.loc.gov/authorities/names/n2016187521 _1http://viaf.org/viaf/279673518
710	2		_aSpringerLink (Online service) _0Local _0http://id.loc.gov/authorities/names/no2005046756 _1http://viaf.org/viaf/148105729 _9106996
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-24097-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9783319240i978
907			_a.b12942741 _b10-10-17 _c21-11-16
942			_2lcc _cLE
945			_aEBOOK EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11613117 _z30-06-17
988			_aSpringer_Medicine_2016
998			_aSI _a_alco _a_vill _b10/2018 _cm _dz _ef _feng _ggw _h0
999			_c84996 _d84996 _x1